NU SKIN ENTERPRISES, INC. (NUS) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 28, 2026
NU SKIN ENTERPRISES, INC. (NUS)
A forensic read on NU SKIN ENTERPRISES, INC. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Safe
Financial health
7.4
Altman Z-score
Clean
Earnings quality
5
Forensic signals
4.7
P / E (ttm)
6.8%
ROE
$256M
Market cap
4.86%
Dividend yield
NU SKIN ENTERPRISES, INC. earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is 7.4, placing it in the Safe zone. 5 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
6%Return on invested capital.Return on invested capital is 6% and slipping from 9% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
2% of revStock-based comp load.Stock-based compensation ran 2% of revenue and 52% of free cash flow in FY2025 — about $0.48 per diluted share. Heavy — a large slice of 'free cash flow' is really being paid out in stock, so the true owner cash per share is well below the headline.
144dInventory days.Days inventory outstanding moved from 126 to 144 FY2024→FY2025 (against cost of goods sold; inventory -6% vs -18% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
-0.1%/yrShare-count dilution.Diluted share count changed -0% over the last 3 years to FY2025 (-0.1%/yr). Roughly flat — buybacks are about offsetting stock comp, not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.
-85%Dividend — cut.The payout was CUT ~85% in FY2024 (from FY2023). It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies — weigh the cut when judging reliability.
Key fundamentals
Net Margin10.8%
Debt / Equity0.28x
Free Cash Flow$46.0M
Latest Revenue$1.49B
Return on Equity19.9%
Revenue Growth YoY-14.3%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on NU SKIN ENTERPRISES, INC.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about NUS's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown